Moreover, mutations of other members of the NF-kB signaling pathway including Bcl-3 and c-Rel have been detected in B-cell leukemia and several types of B-cell lymphomas, respectively [91-94]. This evidence concerns the gene NFKB1 and B-cell non-Hodgkin lymphoma.